165 related articles for article (PubMed ID: 27166130)
21. Mortality and hospital utilization for hepatocellular carcinoma in the United States.
Kim WR; Gores GJ; Benson JT; Therneau TM; Melton LJ
Gastroenterology; 2005 Aug; 129(2):486-93. PubMed ID: 16083705
[TBL] [Abstract][Full Text] [Related]
22. [Influence of treatment of hepatocellular carcinoma before liver transplantation on post transplant tumor recurrence and survival].
Díaz-Sánchez A; Matilla A; Núñez O; Merino B; Peligros I; Rincón D; Salcedo M; Lo Iacono O; Vega Catalina M; Clemente G; Bañares R
Gastroenterol Hepatol; 2010 Mar; 33(3):155-64. PubMed ID: 19945770
[TBL] [Abstract][Full Text] [Related]
23. Assessment of non-surgical versus surgical therapy for localized hepatocellular carcinoma.
Mohanty S; Rajaram R; Bilimoria KY; Salem R; Pawlik TM; Bentrem DJ
J Surg Oncol; 2016 Feb; 113(2):175-80. PubMed ID: 26662882
[TBL] [Abstract][Full Text] [Related]
24. Hospital type- and volume-outcome relationships in esophageal cancer patients receiving non-surgical treatments.
Hsu PK; Chen HS; Wang BY; Wu SC; Liu CY; Shih CH; Liu CC
World J Gastroenterol; 2015 Jan; 21(4):1234-42. PubMed ID: 25632197
[TBL] [Abstract][Full Text] [Related]
25. No difference between lowest and highest volume hospitals in outcome after colorectal cancer surgery in the southern Netherlands.
van Erning FN; van Steenbergen LN; van den Broek WT; Rutten HJ; Lemmens VE
Eur J Surg Oncol; 2013 Nov; 39(11):1199-206. PubMed ID: 24044806
[TBL] [Abstract][Full Text] [Related]
26. Patterns and challenges of treatment sequencing in patients with hepatocellular carcinoma: Experience from a German referral center.
Kirstein MM; Schweitzer N; Winter T; Lappas K; Graen N; Kunstmann I; Voigtländer T; Reineke-Plaaß T; Manns MP; Lehner F; Rodt T; Vogel A
J Gastroenterol Hepatol; 2017 Oct; 32(10):1730-1738. PubMed ID: 28185302
[TBL] [Abstract][Full Text] [Related]
27. Race not rural residency is predictive of surgical treatment for hepatocellular carcinoma: Analysis of the Texas Cancer Registry.
Alawadi ZM; Phatak UR; Kao LS; Ko TC; Wray CJ
J Surg Oncol; 2016 Jan; 113(1):84-8. PubMed ID: 26696033
[TBL] [Abstract][Full Text] [Related]
28. No Difference in Overall Survival Between Hospital Volumes for Patients With Colorectal Cancer in The Netherlands.
Bos AC; van Erning FN; Elferink MA; Rutten HJ; van Oijen MG; de Wilt JH; Lemmens VE
Dis Colon Rectum; 2016 Oct; 59(10):943-52. PubMed ID: 27602925
[TBL] [Abstract][Full Text] [Related]
29. Treatment and prognosis of hepatocellular carcinoma: a population based study in France.
Borie F; Bouvier AM; Herrero A; Faivre J; Launoy G; Delafosse P; Velten M; Buemi A; Peng J; Grosclaude P; Trétarre B
J Surg Oncol; 2008 Dec; 98(7):505-9. PubMed ID: 18932235
[TBL] [Abstract][Full Text] [Related]
30. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies.
Ha J; Yan M; Aguilar M; Tana M; Liu B; Frenette CT; Bhuket T; Wong RJ
J Clin Gastroenterol; 2016; 50(5):423-30. PubMed ID: 26583267
[TBL] [Abstract][Full Text] [Related]
31. Birth cohort-specific disparities in hepatocellular carcinoma stage at diagnosis, treatment, and long-term survival.
Yan M; Ha J; Aguilar M; Bhuket T; Liu B; Gish RG; Cheung R; Wong RJ
J Hepatol; 2016 Feb; 64(2):326-332. PubMed ID: 26386160
[TBL] [Abstract][Full Text] [Related]
32. Management of HCC.
de Lope CR; Tremosini S; Forner A; Reig M; Bruix J
J Hepatol; 2012; 56 Suppl 1():S75-87. PubMed ID: 22300468
[TBL] [Abstract][Full Text] [Related]
33. Survival in relation to hospital type after resection or sorafenib treatment for hepatocellular carcinoma in The Netherlands.
van der Geest LG; van Meer S; Schrier JG; Ijzermans JN; Klümpen HJ; van Erpecum KJ; de Man RA
Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):725-35. PubMed ID: 25846519
[TBL] [Abstract][Full Text] [Related]
34. Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival.
Leykum LK; El-Serag HB; Cornell J; Papadopoulos KP
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):508-12. PubMed ID: 17382601
[TBL] [Abstract][Full Text] [Related]
35. Hepatocellular carcinoma downstaging in liver transplantation.
Yu CY; Ou HY; Huang TL; Chen TY; Tsang LL; Chen CL; Cheng YF
Transplant Proc; 2012 Mar; 44(2):412-4. PubMed ID: 22410030
[TBL] [Abstract][Full Text] [Related]
36. Stratified neutrophil-to-lymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resection.
Huang GQ; Zhu GQ; Liu YL; Wang LR; Braddock M; Zheng MH; Zhou MT
Oncotarget; 2016 Feb; 7(5):5429-39. PubMed ID: 26716411
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant sorafenib after heptectomy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma patients.
Xia F; Wu LL; Lau WY; Huan HB; Wen XD; Ma KS; Li XW; Bie P
World J Gastroenterol; 2016 Jun; 22(23):5384-92. PubMed ID: 27340354
[TBL] [Abstract][Full Text] [Related]
38. [Hepatocellular carcinoma].
Semela D; Heim M
Ther Umsch; 2011 Apr; 68(4):213-7. PubMed ID: 21452143
[TBL] [Abstract][Full Text] [Related]
39. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.
Ruan DY; Lin ZX; Wang TT; Zhao H; Wu DH; Chen J; Dong M; Lin Q; Wu XY; Li Y
Oncotarget; 2016 Sep; 7(38):61378-61389. PubMed ID: 27542216
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of Simultaneous Liver Kidney Transplantation in Patients With Hepatocellular Carcinoma.
Rich N; Tanriover B; Singal AG; Marrero JA
Transplantation; 2017 Jan; 101(1):e12-e19. PubMed ID: 28009759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
